World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

CSL Seqirus at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

CSL Seqirus takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions cover influenza prevention and the front-line response to emerging outbreaks. The most concrete builds the evidence for an MF59-adjuvanted, cell-derived, higher-dose influenza vaccine.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Large pharma
CSL's influenza vaccine business, making seasonal and pandemic influenza vaccines, including adjuvanted and cell-based vaccines.
Talk
Wed Oct 21
10:45
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with UK Health Security Agency (UKHSA), University of Oxford, GSK +1 more

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at CSL Seqirus

Tell us what you sell and we’ll find the people at CSL Seqirus most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction